Jo Leonardi-bee

Biography

Professor Jo Leonardi-Bee was awarded her BSc in Mathematics and Chemistry at the Nottingham Trent University, MSc in Medical Statistics at the University of Leicester, before undertaking her PGCHE and PhD at the University of Nottingham.

Research Interest

Dr Leonardi-Bee heads the Systematic Review Research group. Her main areas of research are the applications of systematic reviews and meta-analysis in the areas of tobacco control and dermatology. Her interests in tobacco control span across the spectrum of this topic, from smoking in pregnancy, smoking uptake in adolescence, smoking cessation to relapse prevention. She is currently involved in a number of trials and projects: Jo is the principal investigator on an award assessing the effectiveness and barriers/facilitators of smoking cessation interventions in Mental Health Services with NICE. She is the methodological lead on "Assessing the effectiveness and barrier/facilitators of smoke-free legislation in secondary care settings" with NICE. Investigating the effectiveness of self-help booklets to aid prevention of relapse to smoking with the Health Technology Assessment (HTA) programme. She is the methodological lead on "Evaluating longer term outcomes of NHS Stop Smoking Services" with the Health Technology Assessment. She is the methodological/statistical lead for "Evaluating the health impacts of smoking in mental health populations" with Cancer Research UK. She is the methodological lead for "Improving effectiveness and reach of NHS support for smoking cessation in pregnancy", which investigates the effectiveness of self-help interventions, such as personalised text messages, designed to help prevent relapse. This trial has been awarded £1.7 million by the National Institute for Health Research (NIHR). Finding new approaches to smoking cessation service delivery, prevention of passive smoke exposure in children, and healthcare cost estimation, which has been awarded £2 million by the NIHR. Involved with dermatology group "Setting Priorities and Reducing Uncertainties in the prevention and treatment of people with Skin Diseases" (SPRUSD), which has been awarded £1.9 million by the NIHR.